- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07609303
Pediatric Solid Organ Transplant Patient Engagement Using an Educational Tablet-Based Game(Mystic Wizard)
Pediatric Solid Organ Transplant Patient Engagement Using an Educational Tablet-Based Game: A Prospective, Mixed Methods Study
Children and teenagers who receive a solid organ transplant (such as a kidney, liver, or heart) must take medications every day to keep their new organ healthy. Taking these medications correctly and on time is one of the most important parts of staying well after a transplant, but it can be hard for young patients to understand why this matters and to keep up with their routines. Doctors and nurses usually teach patients about their transplant through conversations, which may not always be engaging or easy for kids to remember.
This study looks at a new way to help young transplant patients learn about their condition and their medications: an educational game played on a tablet. The purpose of the study is to find out what patients think of the game and how well it works for them. Researchers want to know whether young patients find the game acceptable and enjoyable, whether it is easy to use, whether it makes them feel motivated and capable, and how engaged they feel while playing.
To do this, patients will play the tablet game and then share their experiences. After playing, they will take part in a small group interview where they talk about what they liked, what was confusing, and whether the game helped them understand their transplant and medications. They will also fill out short questionnaires about how easy the game was to use and how engaging it felt.
The researchers' hypothesis is that pediatric solid organ transplant patients will find the educational tablet-based game acceptable, easy to use, and engaging, and that it will be a welcome and helpful tool for learning about their transplant care. The findings will help guide whether this kind of game could be used to support transplant education for children and teens.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Thomas Caruso, MD, PhD
- Telefonní číslo: 650-723-5728
- E-mail: tjcaruso@stanford.edu
Studijní záloha kontaktů
- Jméno: Amrita Narang, MD
- Telefonní číslo: (650) 721-2250
- E-mail: anarang@stanford.edu
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Pediatric solid organ transplant recipient (e.g., liver, kidney, heart)
- Age 7-14 years
- Currently admitted to Lucile Packard Children's Hospital
- Able to understand and interact with a tablet-based game in English
- Parent or legal guardian available to provide consent
Exclusion Criteria:
- Significant cognitive impairment or developmental condition limiting ability to participate in gameplay or surveys
- Acute medical instability
- Severe visual, hearing, or motor impairment preventing interaction with the game
- Non-English speaking participant
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Solid organ transplant recipient
|
Mystic Wizards is a tablet-based serious game intervention designed to support medication understanding, self-efficacy, and health engagement among pediatric solid organ transplant recipients. The game uses a narrative fantasy framework in which players assume the role of a young wizard entrusted with a "Legacy Flame" representing their transplanted organ. Daily medications are represented as "potions" required to maintain the strength and stability of the Flame. The intervention includes short narrative sequences, interactive mini-games, visual feedback systems, and avatar customization features designed to reinforce medication routines and promote empowerment in a developmentally appropriate manner. Participants complete a single gameplay session lasting approximately 10-12 minutes on a tablet device during their inpatient hospitalization, followed by brief surveys and a semi-structured interview. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Determine the acceptability the tablet-based game among solid transplant patient.
Časové okno: Immediately after intervention
|
Semi-structured focus group interviews conducted in person immediately after intervention.
Six core questions plus probing prompts assessing attitudes, opinions, and perceptions of the intervention experience
|
Immediately after intervention
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Evaluate the usability of the tablet-based game among solid transplant patient using System Usability Scale (SUS)
Časové okno: Immediately after intervention
|
The system usability scale (SUS) is a simple, ten-item attitude Likert scale giving a subjective assessments of usability. The measure is scored on a scale from 0 to 100 with 100 indicating higher usability. |
Immediately after intervention
|
|
To assess participants' intrinsic motivation and psychological needs satisfaction (autonomy, competence, relatedness, presence) while using the intervention using Player Experience of Needs Satisfaction (PENS).
Časové okno: Immediately after intervention
|
The PENS scale is a validated, 21-item psychometric questionnaire used to assess participants' psychological experiences during gameplay.
Higher scores correlate with greater psychological satisfaction and long-term treatment adherence.
|
Immediately after intervention
|
|
To assess participants' overall engagement with the digital intervention (focused attention, perceived usability, aesthetic appeal, reward) using User Engagement Scale (UES) - Short.
Časové okno: Immediately after intervention
|
User engagement will be measured by User Engagement Scale (UES) - Short.
This scale consists of 12 items that participants will respond to, reflecting their feelings and interactions with the application or platform.
Each item is rated on a Likert scale ranging from 1 to 5, where 1 indicates "strongly disagree" and 5 indicates "strongly agree."
|
Immediately after intervention
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Thomas Caruso, MD, PhD, Stanford University
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- 87110
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Transplantace pevných orgánů
-
AiCuris Anti-infective Cures AGQuintiles, Inc.DokončenoHCMV reaktivace nebo HCMV End-Organ DiseaseSpojené státy, Německo
-
Abramson Cancer Center of the University of PennsylvaniaStaženoPacienti s rakovinou podstupující transplantaci kmenových buněk (RCT of ACP for Transplant)
-
Peking Union Medical College HospitalNábor
-
Navire Pharma Inc., a BridgeBio companyUkončenoTumor, SolidSpojené státy
-
Evopoint Biosciences Inc.Cancer Institute and Hospital, Chinese Academy of Medical SciencesNábor
-
Peking UniversityZatím nenabíráme
-
Varian, a Siemens Healthineers CompanyDokončeno
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)Ukončeno
-
Merck Sharp & Dohme LLCUkončeno
Klinické studie na Mystic Wizard
-
Kaiser PermanenteHealthPartners Institute; OCHIN, Inc.DokončenoKardiovaskulární choroby | Mrtvice | InfarktSpojené státy
-
University of PittsburghNational Institute of Mental Health (NIMH); Kaiser Foundation Research InstituteDokončeno
-
University of PittsburghNational Institute of Mental Health (NIMH); Kaiser Foundation Research InstituteDokončenoDeprese | Sebevražedné myšlenkySpojené státy
-
HealthPartners InstituteNational Cancer Institute (NCI)Zápis na pozvánkuLynchův syndrom | Dědičná rakovina prsu/ovarií (brca1, brca2) | Dědičné rakovinové syndromy | HBOC syndrom | Genetická variaceSpojené státy
-
HealthPartners InstituteNational Institute on Drug Abuse (NIDA); The Emmes Company, LLC; Geisinger Clinic a další spolupracovníciDokončenoPorucha užívání opioidůSpojené státy
-
HealthPartners InstituteNational Institute on Drug Abuse (NIDA); Hennepin Healthcare Research InstituteDokončenoPorucha užívání opioidůSpojené státy
-
Medical University of WarsawDokončenoDiabetes mellitus 1. typuPolsko